RealTalk MS24 Des 2018

Episode 70: When A Couple Is Living With MS with Dan & Jennifer Digmann

The holiday season seems to carry with it the message of hope, and of finding the best side of who we are. So one of the gifts that I'm going to unwrap with you is a replay of a conversation that I had earlier this year, with 2 people who epitomize hope, humanity, and love. To me, that's what the holiday is all about, and that's what Dan and Jennifer Digmann are all about. Jennifer was diagnosed with Progressive MS in 1997, and Dan was diagnosed with relapsing-remitting MS in 2000. Dan & Jennifer met at a National MS Society event in 2002, and they were married in 2005. We'll get Dan and Jennifer's thoughts about what life is like when both partners in a marriage have been diagnosed with multiple sclerosis. We'll also tell you about the research team that may have identified a biomarker for MS (and why that's a very good thing!). We'll share the results of the Phase III clinical trial data analysis that demonstrates that treatment with Ampyra improves walking ability for people living with MS, we'll tell you about the FDA approval of a Phase II clinical trial for a novel stem cell therapy, and you'll hear about the clinical trial that's about to begin for a new cannabinoid-enriched tablet that can help manage MS pain and spasticity. We have a lot to talk about! Are you ready for RealTalk MS?! ___________

Possible Biomarker for MS Identified 1:51

STUDY: Treatment With Ampyra Improves Walking Ability 5:27

FDA Approves Phase 2 Clinical Trial for NurOwn Stem Cell Therapy 7:57

Clinical Trial Planned for Cannabinoid-Enriched Tablet 9:35

My Interview with Dan & Jennifer Digmann 11:02

___________

LINKS
If your podcast app doesn't allow you to click on these links, you'll find them in the show notes in the RealTalk MS app
or at www.RealTalkMS.com

Download the RealTalk MS App for iOS

Download the RealTalk MS App for Android

Possible Biomarker for Multiple Sclerosis Identified

Assessment of Clinically Meaningful Improvements in Self-Reported Walking Ability in Particpants with Multiple Sclerosis: Results from the Randomized, Double-Blind, Phase III ENHANCE Trial of Prolonged-Release Fampridine

OWC Pharmaceutical Research Corp. Reports the Successful Production of Cannabinoid-Enriched Sublingual Disintegrating Tablet

Dan and Jennifer Digmann

Give RealTalk MS a Rating & Review

___________

Follow RealTalk MS on Twitter, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com.

RealTalk MS Episode 70
Hosted By: Jon Strum
Guest: Dan & Jennifer Digmann

Tags: MS, MultipleSclerosis, RealTalkMS, Ampyra, Cannabis, MSResearch, DanandJenniferDigmann

Denne episoden er hentet fra en åpen RSS-feed og er ikke publisert av Podme. Den kan derfor inneholde annonser.

Episoder(535)

Episode 481: It's Time to Update the Way We Describe MS with Dr. Peter Calabresi

The current clinical language used to describe multiple sclerosis hasn't kept pace with modern neuroscience—and clinging to outdated categories can stall treatment decisions, muddy research, and obscu...

9 Nov 31min

Episode 480: MSToronto 2026 with Dr. Jeffrey Cohen and Dr. Robert Fox

Our coverage of MSToronto 2026 continues this week with two important conversations. First, we'll hear from Dr. Jeffrey Cohen about the latest clinical findings on CAR-T cell therapy as a potential tr...

2 Nov 36min

Episode 479: From MSToronto 2026 with Dr. Bruce Bebo and Kristine Werner Ozug

Last week, about 8,000 MS researchers and clinicians arrived in Toronto, Canada, for MSToronto 2026, the joint meeting of the Americas Committee for Treatment and Research in MS and the European Commi...

29 Okt 45min

Episode 478: From MSToronto 2026 Patient Community Day with Professor Peter Feys and Karen Jacoby

Welcome to a special episode of RealTalk MS and The ECTRIMS Podcast! MS Toronto 2026 concluded with the event we were most looking forward to -- Patient Community Day -- where some of the top MS exper...

26 Okt 22min

Episode 477: One Year After CAR T-Cell Therapy with Jan Janisch-Hanzlik

Jan Janisch-Hanzlik was the first MS patient to receive CAR T-cell therapy as part of a clinical trial. We met Jan last year, in episode 424 of RealTalk MS, when she gave us a first-hand report on how...

19 Okt 30min

Episode 476: MS in the Workplace with Dana Foote

What happens when you're diagnosed with a chronic, unpredictable condition just as your career is taking off? That's exactly what happened to my guest, Dana Foote. This week, Dana joins us to sha...

12 Okt 36min

Episode 475: New Tools and Strategies for Managing MS-Related Cognitive Changes with Dr. Elizabeth Gromisch

Whether it's walking into a room and blanking on why you're there, struggling to pull up a word that's right on the tip of your tongue, or losing track of daily tasks, cognitive fatigue and brain fog ...

5 Okt 30min

Episode 474: The House That MS Built with Sarah Timmerman

Most people don't think about home accessibility until mobility changes force the conversation. But what if you decide to take control of the unknown and design your living space for whatever the futu...

28 Sep 25min